GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (FRA:6Y1) » Definitions » Research & Development

Integrum AB (FRA:6Y1) Research & Development : €0.00 Mil (TTM As of Oct. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Integrum AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Integrum AB's Research & Development for the three months ended in Oct. 2024 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2024 was €0.00 Mil.

Integrum AB Research & Development Historical Data

The historical data trend for Integrum AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB Research & Development Chart

Integrum AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Integrum AB Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Integrum AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB  (FRA:6Y1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Integrum AB Research & Development Related Terms

Thank you for viewing the detailed overview of Integrum AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrum AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (FRA:6Y1) » Definitions » Research & Development
Comparable Companies
OSTO:PAX OSTO:STIL OSTO:PRO OSTO:SPEC OSTO:OSSD OSTO:BOUL OSTO:SEZI OSTO:MNTC OSTO:BRAIN OSTO:EPIS B ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
INTEG B:Sweden
Address
Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Website
http://www.integrum.se
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB Headlines

No Headlines